Skip to content
HowShorted

G1 Therapeutics, Inc. short interest in 2024

In 2024, G1 Therapeutics, Inc.'s disclosed short interest ran from 6.28% of shares outstanding on 12 Jan 2024 to 8.29% on 13 Sep 2024, a change of +2.01 percentage points. The year's high was 13.46% on 15 Jul 2024 and its low 4.67% on 15 Apr 2024, averaging 7.43% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.45 days on 15 Jul 2024. Full history: G1 Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for G1 Therapeutics, Inc. in 2024

2024 in figures

Start of year
6.28% (12 Jan 2024)
End of year
8.29% (13 Sep 2024)
Change
+2.01 pp
High
13.46% (15 Jul 2024)
Low
4.67% (15 Apr 2024)
Average
7.43%
Highest days to cover
8.45 (15 Jul 2024)
SEC filings marked
7

Every report in 2024

G1 Therapeutics, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20246.28%2.46results (8-K)
31 Jan 20245.04%1.64
15 Feb 20246.42%1.47
29 Feb 20245.62%1.7010-K filed, results (8-K)
15 Mar 20245.20%3.61
28 Mar 20245.32%2.74
15 Apr 20244.67%2.99
30 Apr 20245.41%5.19
15 May 20246.86%1.0010-Q filed, results (8-K)
31 May 20247.76%4.33
14 Jun 20249.36%7.24
28 Jun 202410.89%2.41
15 Jul 202413.46%8.45
31 Jul 202411.03%5.92
15 Aug 20248.32%1.0010-Q filed, results (8-K)
30 Aug 20246.46%2.17
13 Sep 20248.29%2.96

See also: G1 Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.